Alpha 2.0
Login Register
» Authors » Leon C Snyman

Leon C Snyman

Explore the profile of Leon C Snyman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 56
Followers 0
Related Specialties
General Medicine
Oncology
Gynecology & Obstetrics
Top 10 Co-Authors
Matthys H Botha
Greta Dreyer
Cathy Visser
Frederick H van der Merwe
Karin L Richter
Radovan Pilka
Daniela Fischerova
Dariusz Wydra
Justin Harvey
Maja Pakiz
Published In
S Afr Med J
Gynecol Oncol
J Low Genit Tract Dis
TH Open
Int J Gynecol Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia
van Rensburg E, Seopela L, Snyman L
Pregnancy Hypertens . 2024 Sep; 38:101155. PMID: 39243692
Objectives: To investigate the relationship between the severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia (PE). Design: Prospective cohort study conducted in Gauteng, South Africaover...
2.
The performance of single and combination test strategies using visual inspection, cytology, high-risk HPV DNA and HPV16/18 to screen South African women with and without HIV-infection
Dreyer G, Visser C, Dreyer G, Botha M, van der Merwe F, Richter K, et al.
Infect Agent Cancer . 2024 May; 19(1):22. PMID: 38725062
Background: Cervical cancer screening strategies should ideally be informed by population-specific data. Strategies recommended for secondary prevention, are often inadequately studied in populations with high cervical disease burdens. This report...
3.
Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate
Botha M, van der Merwe F, Snyman L, Dreyer G, Visser C, Dreyer G
J Low Genit Tract Dis . 2023 Apr; 27(3):212-216. PMID: 37097217
Objective: Screening with primary human papillomavirus (HPV) testing has been evaluated in highly prescreened populations with lower HPV and HIV prevalence than what is the case in South Africa. High...
4.
Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus
Vink F, Meijer C, Lissenberg-Witte B, Visser C, Duin S, Snyman L, et al.
Clin Infect Dis . 2022 Nov; 76(3):416-423. PMID: 36366827
Background: Compared with women who are human immunodeficiency virus (HIV) negative, women with human immunodeficiency virus (WWH) have a higher human papillomavirus (HPV) prevalence and increased cervical cancer risk, emphasizing...
5.
Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials
Dreyer G, Botha M, Snyman L, Visser C, Burden R, Laubscher N, et al.
Int J Gynecol Cancer . 2022 Jan; 32(5):592-598. PMID: 35078829
Objective: The platform provided by human papillomavirus (HPV) vaccination for linked public health interventions to improve cervical cancer prevention remains incompletely explored. The Vaccine And Cervical Cancer Screen (VACCS) cross-sectional...
6.
Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study
Borcinova M, Ragosch V, Jarkovsky J, Bajsova S, Pilka R, Glickman A, et al.
Gynecol Oncol . 2021 Nov; 164(1):76-84. PMID: 34763939
Background: Lower limb lymphoedema (LLL) is the most disabling adverse effect of surgical staging of pelvic lymph nodes. However, the lack of standardisation of volumetric LLL assessment hinders direct comparison...
7.
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial
Cibula D, Kocian R, Plaikner A, Jarkovsky J, Klat J, Zapardiel I, et al.
Eur J Cancer . 2020 Aug; 137:69-80. PMID: 32750501
Background: SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multicentre, prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic lymph node dissection in patients with early-stage cervical cancer. We report the...
8.
Risk Assessment and Management of Venous Thromboembolism in Women during Pregnancy and Puerperium (SAVE): An International, Cross-sectional Study
Gris J, Aoun J, Rzaguliyeva L, Begum R, Salah H, Tugushi T, et al.
TH Open . 2019 Jun; 2(2):e116-e130. PMID: 31249935
The clinical burden of obstetric venous thromboembolism (VTE) risk is inadequately established. This study assessed the prevalence and management of VTE risk during pregnancy and postpartum outside the Western world....
9.
School-based human papillomavirus vaccination: An opportunity to increase knowledge about cervical cancer and improve uptake of screening
Dreyer G, van der Merwe F, Botha M, Snyman L, Constant D, Visser C, et al.
S Afr Med J . 2015 Dec; 105(11):912-6. PMID: 26632317
Background: Poor knowledge about cervical cancer plays a role in limiting screening uptake. HPV vaccination provides an untested platform to distribute information that could possibly improve knowledge and screening coverage....
10.
The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa
Snyman L, Dreyer G, Botha M, Van der Merwe F, Becker P
S Afr Med J . 2015 Aug; 105(2):115-20. PMID: 26242529
Background: Cervical cancer is preventable, but still highly prevalent in South Africa (SA). Screening strategies in the country have been ineffective, and new ways to prevent the disease are needed....